Related Experiment Video
Updated: May 15, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
The Duodenal Microenvironment in Functional Dyspepsia
Pauline Huyghe1, Matthias Ceulemans1, Åsa V Keita2
1Translational Research Centre for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), Katholieke Universiteit Leuven, Leuven, Belgium.
Functional dyspepsia (FD) involves upper abdominal symptoms due to an impaired duodenal barrier and immune activation. These findings challenge the "functional" label and suggest new treatment targets for this common gastrointestinal disorder.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Functional dyspepsia (FD) is a prevalent chronic gastrointestinal disorder with elusive pathophysiology.
- Recent research indicates duodenal microenvironment alterations in FD patients.
- Understanding these changes is crucial for developing effective treatments.
Purpose of the Study:
- To review the duodenal microenvironment in homeostasis and FD.
- To highlight consistent findings and discrepancies across studies.
- To explore potential triggers for duodenal alterations in FD.
Main Methods:
- Literature review focusing on duodenal microenvironment in FD.
- Analysis of molecular and cellular changes in the duodenal mucosa.
- Synthesis of evidence regarding barrier function and immune activation.
Main Results:
- Consistent findings include an impaired duodenal barrier and duodenal immune activation in FD.
- Specific immune cells like eosinophils and mast cells show mucosal activation.
- Potential triggers identified include psychological factors, luminal changes, and food.
Conclusions:
- Evidence suggests molecular and cellular changes in the duodenal microenvironment of FD patients.
- An impaired duodenal barrier and immune activation challenge the purely functional classification of FD.
- These findings offer novel therapeutic targets for FD treatment.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...

